share_log

Alaunos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Boyle Kevin S. Sr.

SEC announcement ·  Sep 5, 2023 17:34
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more